CN Stock MarketDetailed Quotes

300009 Anhui Anke Biotechnology

Watchlist
  • 9.07
  • -0.23-2.47%
Market Closed Dec 13 15:00 CST
15.20BMarket Cap19.42P/E (TTM)

Anhui Anke Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-4.95%1.92B
0.90%1.3B
10.42%656.09M
22.94%2.87B
18.44%2.02B
19.11%1.29B
11.40%594.17M
7.48%2.33B
10.29%1.71B
11.50%1.08B
Operating revenue
-4.95%1.92B
0.90%1.3B
10.42%656.09M
22.94%2.87B
18.44%2.02B
19.11%1.29B
11.40%594.17M
7.48%2.33B
10.29%1.71B
11.50%1.08B
Other operating revenue
----
-0.16%1.67M
----
9.36%4.57M
----
-57.35%1.67M
----
-50.78%4.18M
----
53.18%3.91M
Total operating cost
0.84%1.27B
1.93%842.21M
9.33%412.63M
23.73%1.93B
18.57%1.26B
19.74%826.26M
10.54%377.41M
0.24%1.56B
0.06%1.06B
-0.33%690.06M
Operating cost
-2.77%427.57M
-1.36%282.54M
0.92%148.03M
23.24%620.34M
27.66%439.77M
33.21%286.43M
40.91%146.68M
16.41%503.37M
20.12%344.49M
17.19%215.02M
Operating tax surcharges
-4.77%16.29M
-0.91%11.33M
7.82%5.62M
27.37%24.61M
24.47%17.11M
28.92%11.44M
9.45%5.21M
-0.76%19.32M
-0.51%13.74M
-1.66%8.87M
Operating expense
9.93%569.87M
10.39%381.24M
14.91%171.82M
13.21%831.32M
2.60%518.39M
-0.22%345.36M
-13.75%149.53M
-9.61%734.35M
-10.97%505.24M
-8.59%346.13M
Administration expense
-3.34%127.5M
3.94%86.84M
21.01%50.4M
45.74%203.35M
45.77%131.91M
38.07%83.55M
36.27%41.65M
5.19%139.53M
-2.91%90.49M
-5.93%60.51M
Financial expense
38.15%-1.46M
22.10%-1.13M
59.61%-417.04K
-59.17%-3.81M
-109.07%-2.36M
-114.81%-1.45M
-197.27%-1.03M
66.24%-2.39M
40.40%-1.13M
59.41%-672.96K
-Interest expense (Financial expense)
68.22%2.09M
85.79%1.44M
138.60%870.4K
23.13%1.87M
26.08%1.24M
16.81%776.49K
14.17%364.79K
-1.32%1.52M
-13.19%983.79K
-15.06%664.76K
-Interest Income (Financial expense)
9.67%-4.23M
3.85%-2.89M
6.67%-1.51M
-22.56%-5.89M
-45.66%-4.69M
-40.43%-3.01M
-74.11%-1.62M
11.23%-4.81M
7.63%-3.22M
20.32%-2.14M
Research and development
-15.94%128.57M
-19.36%81.39M
5.09%37.18M
53.41%254.68M
41.69%152.94M
67.65%100.93M
22.00%35.38M
-0.32%166.01M
7.17%107.94M
2.91%60.2M
Credit Impairment Loss
172.06%4.56M
186.30%2.71M
162.86%1.06M
-191.39%-20.15M
-138.52%-6.32M
25.82%-3.14M
65.75%-1.69M
235.43%22.05M
541.25%16.42M
-91.21%-4.24M
Asset Impairment Loss
-3,800.18%-359.41K
-494.72%-359.41K
-287.01%-68.68K
36.63%-17.48M
94.90%-9.22K
169.01%91.06K
150.13%36.72K
92.03%-27.59M
-267.45%-180.78K
-222.22%-131.95K
Other net revenue
858.89%46.43M
1,300.00%36.39M
349.05%14.14M
-115.85%-11.27M
-91.97%4.84M
-91.00%2.6M
-75.14%3.15M
122.59%71.13M
236.98%60.32M
152.73%28.89M
Fair value change income
-202.42%-2.57M
165.14%1.21M
520.15%3.5M
-101.13%-411.05K
8.81%2.51M
-215.01%-1.86M
-73.75%564.01K
87.66%36.3M
-70.36%2.3M
-61.35%1.62M
Invest income
598.85%14.7M
280.61%7.25M
202.32%1.3M
-198.81%-4.74M
-121.90%-2.95M
-76.16%1.91M
-82.46%431.08K
-21.34%4.8M
19,072.82%13.46M
2,834.63%7.99M
-Including: Investment income associates
17.90%-16.04M
-0.89%-11.56M
-8.96%-5.31M
-55.20%-31.71M
-162.13%-19.54M
-221.05%-11.46M
-114.69%-4.88M
-17.57%-20.43M
22.71%-7.45M
53.89%-3.57M
Asset deal income
243,427.04%925.23K
68,501.48%1.09M
--995.96K
110.05%120.7K
99.98%-380.24
-113.68%-1.59K
----
-171.37%-1.2M
-194.51%-1.59M
-99.31%11.65K
Other revenue
151.02%29.16M
336.68%24.48M
93.24%7.35M
-14.61%31.4M
-61.15%11.62M
-76.28%5.61M
-70.88%3.8M
78.64%36.77M
146.38%29.91M
196.54%23.64M
Operating profit
-8.99%699.36M
6.34%493M
17.14%257.6M
9.74%923.98M
8.81%768.47M
10.50%463.62M
7.49%219.91M
183.08%841.99M
39.79%706.22M
45.50%419.55M
Add:Non operating Income
2,230.90%712.57K
6,344.13%562.79K
435.71%20K
-73.66%65.18K
-86.95%30.57K
-94.72%8.73K
33,932.27%3.73K
-16.49%247.4K
-16.91%234.18K
8,169.68%165.41K
Less:Non operating expense
147.30%1.8M
1,230.55%1.54M
-97.19%1.4K
-50.98%4.11M
-87.18%728.51K
-97.87%115.86K
58.44%49.84K
220.74%8.39M
78.11%5.68M
3,904.59%5.45M
Total profit
-9.05%698.28M
6.15%492.02M
17.17%257.62M
10.32%919.93M
9.56%767.78M
11.89%463.51M
7.48%219.86M
182.55%833.85M
39.52%700.77M
43.73%414.27M
Less:Income tax cost
-4.65%98.36M
10.71%68.25M
15.04%35.68M
-36.23%61.34M
7.74%103.16M
-1.30%61.64M
12.40%31.01M
4.86%96.19M
35.10%95.74M
50.68%62.45M
Net profit
-9.74%599.92M
5.45%423.77M
17.52%221.94M
16.39%858.59M
9.85%664.62M
14.23%401.86M
6.72%188.85M
262.69%737.66M
40.24%605.03M
42.57%351.81M
Net profit from continuing operation
-9.74%599.92M
5.45%423.77M
17.52%221.94M
16.39%858.59M
9.85%664.62M
14.23%401.86M
6.72%188.85M
262.69%737.66M
40.24%605.03M
42.57%351.81M
Less:Minority Profit
-0.10%10.2M
38.69%7.64M
29.69%4.19M
-66.97%11.36M
-4.91%10.21M
-25.21%5.51M
-20.43%3.23M
1,160.57%34.4M
427.50%10.73M
166.08%7.36M
Net profit of parent company owners
-9.89%589.72M
4.99%416.13M
17.31%217.75M
20.47%847.23M
10.12%654.41M
15.07%396.36M
7.36%185.62M
240.35%703.26M
38.41%594.3M
41.17%344.45M
Earning per share
Basic earning per share
-10.26%0.35
4.17%0.25
18.18%0.13
18.60%0.51
8.33%0.39
14.29%0.24
0.00%0.11
230.77%0.43
38.46%0.36
40.00%0.21
Diluted earning per share
-10.26%0.35
4.17%0.25
18.18%0.13
18.60%0.51
8.33%0.39
14.29%0.24
0.00%0.11
230.77%0.43
38.46%0.36
40.00%0.21
Other composite income
Total composite income
-9.74%599.92M
5.45%423.77M
17.52%221.94M
16.39%858.59M
9.85%664.62M
14.23%401.86M
6.72%188.85M
262.69%737.66M
40.24%605.03M
42.57%351.81M
Total composite income of parent company owners
-9.89%589.72M
4.99%416.13M
17.31%217.75M
20.47%847.23M
10.12%654.41M
15.07%396.36M
7.36%185.62M
240.35%703.26M
38.41%594.3M
41.17%344.45M
Total composite income of minority owners
-0.10%10.2M
38.69%7.64M
29.69%4.19M
-66.97%11.36M
-4.91%10.21M
-25.21%5.51M
-20.43%3.23M
1,160.57%34.4M
427.50%10.73M
166.08%7.36M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -4.95%1.92B0.90%1.3B10.42%656.09M22.94%2.87B18.44%2.02B19.11%1.29B11.40%594.17M7.48%2.33B10.29%1.71B11.50%1.08B
Operating revenue -4.95%1.92B0.90%1.3B10.42%656.09M22.94%2.87B18.44%2.02B19.11%1.29B11.40%594.17M7.48%2.33B10.29%1.71B11.50%1.08B
Other operating revenue -----0.16%1.67M----9.36%4.57M-----57.35%1.67M-----50.78%4.18M----53.18%3.91M
Total operating cost 0.84%1.27B1.93%842.21M9.33%412.63M23.73%1.93B18.57%1.26B19.74%826.26M10.54%377.41M0.24%1.56B0.06%1.06B-0.33%690.06M
Operating cost -2.77%427.57M-1.36%282.54M0.92%148.03M23.24%620.34M27.66%439.77M33.21%286.43M40.91%146.68M16.41%503.37M20.12%344.49M17.19%215.02M
Operating tax surcharges -4.77%16.29M-0.91%11.33M7.82%5.62M27.37%24.61M24.47%17.11M28.92%11.44M9.45%5.21M-0.76%19.32M-0.51%13.74M-1.66%8.87M
Operating expense 9.93%569.87M10.39%381.24M14.91%171.82M13.21%831.32M2.60%518.39M-0.22%345.36M-13.75%149.53M-9.61%734.35M-10.97%505.24M-8.59%346.13M
Administration expense -3.34%127.5M3.94%86.84M21.01%50.4M45.74%203.35M45.77%131.91M38.07%83.55M36.27%41.65M5.19%139.53M-2.91%90.49M-5.93%60.51M
Financial expense 38.15%-1.46M22.10%-1.13M59.61%-417.04K-59.17%-3.81M-109.07%-2.36M-114.81%-1.45M-197.27%-1.03M66.24%-2.39M40.40%-1.13M59.41%-672.96K
-Interest expense (Financial expense) 68.22%2.09M85.79%1.44M138.60%870.4K23.13%1.87M26.08%1.24M16.81%776.49K14.17%364.79K-1.32%1.52M-13.19%983.79K-15.06%664.76K
-Interest Income (Financial expense) 9.67%-4.23M3.85%-2.89M6.67%-1.51M-22.56%-5.89M-45.66%-4.69M-40.43%-3.01M-74.11%-1.62M11.23%-4.81M7.63%-3.22M20.32%-2.14M
Research and development -15.94%128.57M-19.36%81.39M5.09%37.18M53.41%254.68M41.69%152.94M67.65%100.93M22.00%35.38M-0.32%166.01M7.17%107.94M2.91%60.2M
Credit Impairment Loss 172.06%4.56M186.30%2.71M162.86%1.06M-191.39%-20.15M-138.52%-6.32M25.82%-3.14M65.75%-1.69M235.43%22.05M541.25%16.42M-91.21%-4.24M
Asset Impairment Loss -3,800.18%-359.41K-494.72%-359.41K-287.01%-68.68K36.63%-17.48M94.90%-9.22K169.01%91.06K150.13%36.72K92.03%-27.59M-267.45%-180.78K-222.22%-131.95K
Other net revenue 858.89%46.43M1,300.00%36.39M349.05%14.14M-115.85%-11.27M-91.97%4.84M-91.00%2.6M-75.14%3.15M122.59%71.13M236.98%60.32M152.73%28.89M
Fair value change income -202.42%-2.57M165.14%1.21M520.15%3.5M-101.13%-411.05K8.81%2.51M-215.01%-1.86M-73.75%564.01K87.66%36.3M-70.36%2.3M-61.35%1.62M
Invest income 598.85%14.7M280.61%7.25M202.32%1.3M-198.81%-4.74M-121.90%-2.95M-76.16%1.91M-82.46%431.08K-21.34%4.8M19,072.82%13.46M2,834.63%7.99M
-Including: Investment income associates 17.90%-16.04M-0.89%-11.56M-8.96%-5.31M-55.20%-31.71M-162.13%-19.54M-221.05%-11.46M-114.69%-4.88M-17.57%-20.43M22.71%-7.45M53.89%-3.57M
Asset deal income 243,427.04%925.23K68,501.48%1.09M--995.96K110.05%120.7K99.98%-380.24-113.68%-1.59K-----171.37%-1.2M-194.51%-1.59M-99.31%11.65K
Other revenue 151.02%29.16M336.68%24.48M93.24%7.35M-14.61%31.4M-61.15%11.62M-76.28%5.61M-70.88%3.8M78.64%36.77M146.38%29.91M196.54%23.64M
Operating profit -8.99%699.36M6.34%493M17.14%257.6M9.74%923.98M8.81%768.47M10.50%463.62M7.49%219.91M183.08%841.99M39.79%706.22M45.50%419.55M
Add:Non operating Income 2,230.90%712.57K6,344.13%562.79K435.71%20K-73.66%65.18K-86.95%30.57K-94.72%8.73K33,932.27%3.73K-16.49%247.4K-16.91%234.18K8,169.68%165.41K
Less:Non operating expense 147.30%1.8M1,230.55%1.54M-97.19%1.4K-50.98%4.11M-87.18%728.51K-97.87%115.86K58.44%49.84K220.74%8.39M78.11%5.68M3,904.59%5.45M
Total profit -9.05%698.28M6.15%492.02M17.17%257.62M10.32%919.93M9.56%767.78M11.89%463.51M7.48%219.86M182.55%833.85M39.52%700.77M43.73%414.27M
Less:Income tax cost -4.65%98.36M10.71%68.25M15.04%35.68M-36.23%61.34M7.74%103.16M-1.30%61.64M12.40%31.01M4.86%96.19M35.10%95.74M50.68%62.45M
Net profit -9.74%599.92M5.45%423.77M17.52%221.94M16.39%858.59M9.85%664.62M14.23%401.86M6.72%188.85M262.69%737.66M40.24%605.03M42.57%351.81M
Net profit from continuing operation -9.74%599.92M5.45%423.77M17.52%221.94M16.39%858.59M9.85%664.62M14.23%401.86M6.72%188.85M262.69%737.66M40.24%605.03M42.57%351.81M
Less:Minority Profit -0.10%10.2M38.69%7.64M29.69%4.19M-66.97%11.36M-4.91%10.21M-25.21%5.51M-20.43%3.23M1,160.57%34.4M427.50%10.73M166.08%7.36M
Net profit of parent company owners -9.89%589.72M4.99%416.13M17.31%217.75M20.47%847.23M10.12%654.41M15.07%396.36M7.36%185.62M240.35%703.26M38.41%594.3M41.17%344.45M
Earning per share
Basic earning per share -10.26%0.354.17%0.2518.18%0.1318.60%0.518.33%0.3914.29%0.240.00%0.11230.77%0.4338.46%0.3640.00%0.21
Diluted earning per share -10.26%0.354.17%0.2518.18%0.1318.60%0.518.33%0.3914.29%0.240.00%0.11230.77%0.4338.46%0.3640.00%0.21
Other composite income
Total composite income -9.74%599.92M5.45%423.77M17.52%221.94M16.39%858.59M9.85%664.62M14.23%401.86M6.72%188.85M262.69%737.66M40.24%605.03M42.57%351.81M
Total composite income of parent company owners -9.89%589.72M4.99%416.13M17.31%217.75M20.47%847.23M10.12%654.41M15.07%396.36M7.36%185.62M240.35%703.26M38.41%594.3M41.17%344.45M
Total composite income of minority owners -0.10%10.2M38.69%7.64M29.69%4.19M-66.97%11.36M-4.91%10.21M-25.21%5.51M-20.43%3.23M1,160.57%34.4M427.50%10.73M166.08%7.36M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Monoclonal Antibody Concept
Monoclonal Antibody Concept
Intraday-1.90%